Timeline
4basebio wins opDNA supply deal for Phase II immunotherapy trial
Big Pharma's AI arms race intensifies as Bristol Myers Squibb hands Anthropic the keys to the enterprise
Health & Bio Today: AstraZeneca wins dual FDA approvals, Advanced Medical Solutions, CelLBxHealth, GSK
CelLBxHealth to deploy Parsortix with AdventHealth for two US clinical studies
ValiRx raises up to £1.155m to fund McGill in‑licence, Cytolytix preclinical work and animal‑health expansion
GSK lands expanded approval for RSV vaccine Arexvy in Japan
AstraZeneca secures US approval for blood pressure drug Baxfendy
AstraZeneca's breast cancer drug Enhertu cleared by FDA
AstraZeneca says Imfinzi plus enfortumab vedotin improves survival in muscle‑invasive bladder cancer
Poolbeg to present POLB 001 CRS data at EHA
Health & Bio Today: Adaptix wins CE mark for Ortho350, Physiomics, IXICO, Novo Nordisk
IP Group's Enterprise Therapeutics hits primary endpoint in Phase 2 cystic fibrosis trial
Physiomics appoints Stewart Williams as consultant
The Premarket Brief: Marston's reaffirms FY2026 guidance on margin gains, Angling Direct, Greggs, Wickes, Novo Nordisk, Wizz Air
Novo Nordisk says early responders to Wegovy 7.2 mg lose 27.7% at 72 weeks
Poolbeg Pharma wins Canadian patent for POLB 001 CRS use
GSK strikes exclusive China collab to roll out bepirovirsen
Avacta says pre|CISION releases payload faster and more selectively than approved ADCs
Abingdon Health named CDMO and manufacturer for 4TEEN4's diagnostic
Health & Bio Today: BSF Enterprise auctions T-Rex leather at Drouot, genedrive, ImmuPharma, Creo Medical, hVIVO
Fusion Antibodies shares dip after year-end trading statement
ImmuPharma launches IND‑enabling programme for Kapiglucagon with tranScrip
Shield Therapeutics reports 54% growth in ACCRUFeR sales, but warns over impact of Medicaid changes
AstraZeneca's Truqap recommended by FDA advisory panel for a form of prostate cancer
AstraZeneca fails to win FDA advisory backing for camizestrant
Tech Today: Built Cybernetics, Visum, Weir Group, Sage, ZOO Digital
Health & Bio Today: GSK drops despite strong Q1, SkinBioTherapeutics, Solvonis, AstraZeneca, Ondine Biomedical
Tech Today: Smarter Web, Sage, MedPal AI, Shearwater, ZOO Digital, AstraZeneca, Ondine Biomedical
Solvonis to prioritise Phase 3 for lead asset
MedPal AI buys Remedi Runcorn pharmacy, adding a £10m patient book
The Premarket Brief: GSK, Lloyds, AstraZeneca, Prudential, Haleon, Ondine Biomedical, Halfords, Frasers Group, Treatt
GSK cheers strong start to 2026, maintains FY guidance
AstraZeneca repeats 2026 guidance as Q1 revenue rises 8%
Haleon sees quarter of revenue growth driven by oral health brands
Health & Bio Today: GSK, AstraZeneca, Hemogenyx Pharmaceuticals, Genflow Biosciences
Hemogenyx Pharmaceuticals shares fall after £3m fundraising
Genflow Biosciences shares higher as 'tier-1' talks advance
Quantum Data Energy starts Bordesley construction as £1m placing backs pipeline
GSK wins FDA priority review and breakthrough tag for bepirovirsen
AstraZeneca wins US approval for Breztri in asthma
Health & Bio Today: GSK's efimosfermin wins FDA Breakthrough and EMA PRIME status, PureTech Health, Ondine Biomedical, AstraZeneca
Seaport Therapeutics appoints Intra‑Cellular founder Sharon Mates to board
GSK's efimosfermin sees FDA Breakthrough
AstraZeneca wins US approval for once-weekly Saphnelo self-injection
GSK subsidiary TESARO has anticipatory breach claim dismissed by Delaware court
The Premarket Brief: ECR Minerals, Ondine Biomedical, 88 Energy, Pathos Communications, Beowulf Mining
Shield Therapeutics partner MEDLEAP confirms first patient enrollment in Japan Phase II for ACCRUFeR
Hikma reiterates full-year 2026 guidance after encouraging start to the year
PureTech posts positive Phase 1b LYT-200 data and will prioritise relapsed/refractory high‑risk MDS
More in Healthcare
Genedrive's personalised medicine receives Parliament boost
A government minister named Genedrive's newborn hearing-loss test as a live example of personalised medicine during a House of Commons committee session.